Sinovac Biotech (NASDAQ:SVA) reported quarterly losses of $(0.84) per share. This is a 1500 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $147.079 million in sales this quarter. This is a 12.90 percent increase over sales of $130.270 million the same period last year.